PMID- 35928495 OWN - NLM STAT- MEDLINE DCOM- 20220808 LR - 20220811 IS - 2296-2565 (Electronic) IS - 2296-2565 (Linking) VI - 10 DP - 2022 TI - Spending and Hospital Stay for Melanoma in Hunan, China. PG - 917119 LID - 10.3389/fpubh.2022.917119 [doi] LID - 917119 AB - OBJECTIVE: This study aimed to describe the economic burden of Chinese patients with melanoma in Hunan province of China, and to investigate the factors for hospitalization spending and length of stay (LOS) in patients undergoing melanoma surgery. METHODS: Data was extracted from the Chinese National Health Statistics Network Reporting System database in Hunan province during 2017-2019. Population and individual statistics were presented, and nonparametric tests and quantile regression were used to analyze the factors for spending and LOS. RESULT: A total of 2,644 hospitalized patients with melanoma in Hunan were identified. During 2017-2019, the total hospitalization spending was $5,247,972, and out-of-pocket payment (OOP) was $1,817,869, accounting for 34.6% of the total expenditure. The median spending was $1,123 [interquartile range (IQR): $555-2,411] per capita, and the median LOS was 10 days (IQR: 5-18). A total of 1,104 patients who underwent surgery were further analyzed. The non-parametric tests and quantile regression showed that women were associated with less spending and LOS than men. In general, patients aged 46-65 and those with lesions on the limbs had higher hospitalization costs and LOS than other subgroups. CONCLUSION: Melanoma causes heavy economic burdens on patients in Hunan, such that the median spending is close to 60% of the averagely annual disposable income. Middle-aged men patients with melanoma on the limbs present the highest financial burden of melanoma. CI - Copyright (c) 2022 Ke, Lin, Li, Zhao, Chen, Xiao, Chen, Shen and Su. FAU - Ke, Xinchen AU - Ke X AD - Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China. AD - Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, China. AD - Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China. AD - National Clinical Research Center of Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China. FAU - Lin, Wenrui AU - Lin W AD - Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China. AD - Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, China. AD - Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China. AD - National Clinical Research Center of Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China. FAU - Li, Daishi AU - Li D AD - Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China. AD - Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, China. AD - Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China. AD - National Clinical Research Center of Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China. FAU - Zhao, Shuang AU - Zhao S AD - Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China. AD - Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, China. AD - Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China. AD - National Clinical Research Center of Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China. FAU - Chen, Mingliang AU - Chen M AD - Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China. AD - Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, China. AD - Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China. AD - National Clinical Research Center of Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China. FAU - Xiao, Yi AU - Xiao Y AD - Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China. AD - Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, China. AD - Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China. AD - National Clinical Research Center of Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China. FAU - Chen, Xiang AU - Chen X AD - Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China. AD - Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, China. AD - Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China. AD - National Clinical Research Center of Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China. FAU - Shen, Minxue AU - Shen M AD - Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China. AD - Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, China. AD - Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China. AD - Department of Social Medicine and Health Management, Xiangya School of Public Health, Central South University, Changsha, China. FAU - Su, Juan AU - Su J AD - Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China. AD - Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, China. AD - Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, China. AD - National Clinical Research Center of Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20220719 PL - Switzerland TA - Front Public Health JT - Frontiers in public health JID - 101616579 SB - IM MH - China/epidemiology MH - Female MH - *Health Expenditures MH - Hospitalization MH - Humans MH - Length of Stay MH - Male MH - *Melanoma/surgery MH - Middle Aged PMC - PMC9343693 OTO - NOTNLM OT - Chinese hospitalization spending OT - economic burden OT - length of stay OT - melanoma OT - surgery COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor RH declared a shared affiliation with the authors at the time of review. EDAT- 2022/08/06 06:00 MHDA- 2022/08/09 06:00 PMCR- 2022/07/19 CRDT- 2022/08/05 02:12 PHST- 2022/04/10 00:00 [received] PHST- 2022/06/20 00:00 [accepted] PHST- 2022/08/05 02:12 [entrez] PHST- 2022/08/06 06:00 [pubmed] PHST- 2022/08/09 06:00 [medline] PHST- 2022/07/19 00:00 [pmc-release] AID - 10.3389/fpubh.2022.917119 [doi] PST - epublish SO - Front Public Health. 2022 Jul 19;10:917119. doi: 10.3389/fpubh.2022.917119. eCollection 2022.